CIK 0001355790 · Non-accelerated filer<br>Smaller reporting company
International Stem Cell CORP
Sign in to watch- Ticker
- ISCO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204494098
- Phone
- 760-940-6383
- Business address
- 9745 BUSINESSPARK AVENUE, SAN DIEGO, CA, 92131
- Former names
- BTHC III INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,497
- in 1 filing
Net −$10,497. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-31 | Kern Russell EVP and CSO | Grant or award · Stock Option (Right to Buy) | −40,000 | 40,000 | ||
| 2017-05-31 | Garnette Sophia VP, Legal Affairs & Operations | Grant or award · Stock Option (Right to Buy) | −60,000 | 60,000 | ||
| 2017-05-31 | Ebrahimi Mahnaz Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | −40,000 | 40,000 | ||
| 2017-05-22 | Semechkin Andrey Chief Executive Officer | Purchase | +3,200 | $1.64 | $5K | 1,528,450 |
| 2017-03-31 | Don Wright Director | Grant or award | +4,642 | 34,639 | ||
| 2017-03-31 | MAIER PAUL V Director | Grant or award | +4,642 | 33,060 | ||
| 2017-03-31 | CASAMENTO CHARLES J Director | Grant or award | +4,642 | 34,139 | ||
| 2017-03-22 | Semechkin Andrey Chief Executive Officer | Purchase | +3,000 | $1.69 | $5K | 1,525,250 |
| 2017-03-21 | Semechkin Andrey Chief Executive Officer | Purchase | +500 | $1.60 | $800 | 1,522,250 |
| 2017-03-20 | Semechkin Andrey Chief Executive Officer | Purchase | +6,500 | $1.66 | $11K | 1,521,750 |
| 2017-03-14 | Semechkin Andrey Chief Executive Officer | Purchase | +2,100 | $1.59 | $3K | 1,515,250 |
| 2017-03-13 | Semechkin Andrey Chief Executive Officer | Purchase | +1,000 | $1.50 | $2K | 1,513,150 |
| 2017-03-10 | Semechkin Andrey Chief Executive Officer | Purchase | +5,000 | $1.32 | $7K | 1,512,150 |
| 2017-02-10 | Semechkin Andrey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | −100,000 | 100,000 | ||
| 2017-02-10 | Kern Russell EVP and CSO | Grant or award · Stock Option (Right to Buy) | −90,000 | 90,000 | ||
| 2017-02-10 | Garnette Sophia VP, Legal Affairs & Operation | Grant or award · Stock Option (Right to Buy) | −20,000 | 20,000 | ||
| 2017-02-10 | Ebrahimi Mahnaz Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | −40,000 | 40,000 | ||
| 2016-12-30 | Don Wright Director | Grant or award | +7,523 | 29,997 | ||
| 2016-12-30 | MAIER PAUL V Director | Grant or award | +7,523 | 28,418 | ||
| 2016-12-30 | CASAMENTO CHARLES J Director | Grant or award | +7,523 | 29,497 |
Page 8 of 9 · 166 trades